Bianzano S, Rose S, Nordaby M, Plum-Morschel L, et al. Safety, tolerability, pharmacodynamics and pharmacokinetics following once-daily doses of BI 187004, an inhibitor of 11 beta-hydroxysteroid dehydrogenase-1, over 28 days in patients with type 2 diabetes mellitus and overweight or obesity. Diabetes Obes Metab 2022 Dec 7. doi: 10.1111/dom.14932.
PMID: 36478142